Innovent Biologics, Inc. 01801.HK 價格預測與預測

Q: 技術分析指標如何適用於 01801.HK？

根據技術分析，Innovent Biologics, Inc. 的綜合信號為 Buy。Innovent Biologics, Inc. 有 3 個買入信號，2 個中性信號和 2 個賣出信號。

Q: 01801.HK 的費波那契回檔水準是多少？

Innovent Biologics, Inc. 的費波那契回檔水準是 高於 0% 水準。

Q: Innovent Biologics, Inc. 的 RSI 是多少？

Innovent Biologics, Inc. 的 RSI 目前為 34.21，表明處於 中立 狀態

Q: Innovent Biologics, Inc. 接下來 12 個月的價格是多少？

Innovent Biologics, Inc. 01801.HK 接下來 12 個月的價格預估為 $0。

Q: Innovent Biologics, Inc. 預計會漲到多高？

據華爾街分析師稱，Innovent Biologics, Inc. 預計將達到 $0 的高預測值。

首頁

股票

01801.HK

預測

INNOVENT BIO (01801.HK)

Innovent Biologics, Inc.

HK$82.8

-0.83%

$-0.7

休市： Jan 21, 16:00:00 HKT

關鍵數據

前收市價

$83.2

開盤價

$83.5

當日範圍

$81.55 - $83.75

52週區間

$28.65 - $109.1

交易量

9.1M

平均成交量

14.6M

每股盈餘 (TTM)

0.75

股息收益率

市值

$142.4B

什麼是 INNOVENT BIO？

Innovent Biologics, Inc. is a biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases. The company is headquartered in Suzhou, Jiangsu and currently employs 6,190 full-time employees. The company went IPO on 2018-10-31. The pipeline covering monoclonal antibodies, multi-specific antibodies, immuno-cytokine, antibody-drug conjugates (ADCs), cell therapy and small molecules. The Company’s main products include TYVYT (sintilimab injection), BYVASDA (bevacizumab injection), SULINNO (adalimumab injection), HALPRYZA (rituximab injection), Pemazyre (pemigatinib) and others. The firm mainly conducts its businesses within domestic and overseas markets.

功能特性

交易策略

資源

市場

01801.HK 股價預測摘要

01801.HK stock price ended at $83.2 on 星期二, after dropping 2.52%

On the latest trading day Jan 20, 2026, the stock price of 01801.HK fell by 2.52%, dropping from $85.10 to $83.20. During the session, the stock saw a volatility of 3.99%, with prices oscillating between a daily low of $82.75 and a high of $86.05. On the latest trading day, the trading volume for 01801.HK decreased by 5.1M shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 9.1M shares were traded, with a market value of approximately $143.1B.

01801.HK 技術面訊號

技術面訊號摘要

購買訊號 3

中性訊號 2

賣出訊號 2

Strong Sell

Sell

Neutral

Buy

Strong Buy

01801.HK 目前顯示 3 個買入訊號與 2 個賣出訊號。該股票自 12:00 AM 以來一直處於下跌趨勢狀態，在此期間價格總共變動了 -7.04%。整體而言，技術指標顯示中期後市趨勢為 Buy。

01801.HK 的看漲／看跌訊號

我們的演算法透過分析移動平均線、RSI、MACD 和成交量等關鍵指標，為01801.HK生成看漲和看跌訊號。這些見解可助您做出明智的投資決策。

後續問題

技術分析指標如何適用於 01801.HK？



01801.HK 的費波那契回檔水準是多少？



Innovent Biologics, Inc. 的 RSI 是多少？



Innovent Biologics, Inc. 接下來 12 個月的價格是多少？



Innovent Biologics, Inc. 預計會漲到多高？



Innovent Biologics, Inc.（01801.HK）價格

01801.HK 股價走勢圖